New Advances in COVID-19 and Pregnancy
Based on what is known at this time, pregnant women are at an increased risk of severe illness from COVID-19 compared to nonpregnant women. Additionally, pregnant women with COVID-19 might have an increased risk of adverse pregnancy outcomes. Therefore, there is a need to investigate the effects of...
Guardat en:
| Format: | Online |
|---|---|
| Idioma: | anglès |
| Publicat: |
MDPI - Multidisciplinary Digital Publishing Institute
2026
|
| Matèries: | |
| Accés en línia: | ONIX_20260416T142754_9783725859115_22 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
| Sumari: | Based on what is known at this time, pregnant women are at an increased risk of severe illness from COVID-19 compared to nonpregnant women. Additionally, pregnant women with COVID-19 might have an increased risk of adverse pregnancy outcomes. Therefore, there is a need to investigate the effects of coronavirus disease 2019 (COVID-19) on the mortality of pregnant and postpartum women. Worldwide, there are more than 140 million births every year, and pregnant women are potentially at risk for adverse outcomes of novel coronavirus. Although maternal mortality has been reported in some studies, limited information is available about SARS-CoV-2 infection in critically ill pregnant women who are hospitalized for COVID-19. This Special Issue summarizes well-established data on the clinical manifestation of COVID-19 in pregnant women, maternal and perinatal outcomes associated with COVID-19, the risk of vertical transmission of the virus, and the effect of SARS-COV-2 infection during pregnancy on fetal and neonatal outcomes. The data provided by the papers included in this Special Issue will allow researchers to determine the maternal, fetal, and neonatal risk associated with SARS-COV-2 infection during pregnancy and may help to provide evidenced-based and personalized recommendations for the care of pregnant women with COVID-19. |
|---|